{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:27:38Z","timestamp":1794590858171,"version":"4.9.1"},"reference-count":32,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Myelodysplastic syndrome (MDS) is a heterogeneous myeloid malignant neoplasm driven by hematopoietic stem cell dysfunction, leading to ineffective hematopoiesis and cytopenias. Familial GATA2 deficiency is the most common cause of MDS in adolescents, with progression often accelerated by co-occurring mutations, notably STAG2 loss of function. Using CRISPR\/Cas9-mediated genome engineering in primary human fetal liver\u2013derived hematopoietic stem cells and xenotransplantation in mice, we modeled GATA2-deficient MDS with acquired STAG2 loss to investigate disease initiation and progression. Although GATA2 deficiency alone had minimal short-term impact in our model, combined GATA2 deficiency and STAG2 loss increased hematopoietic stem cell maintenance and self-renewal, induced a myeloid-lineage bias, and expanded primitive progenitors. Single-cell transcriptional profiling revealed upregulation of stemness-associated genes and inflammatory pathways. This humanized model faithfully recapitulates high-risk GATA2-deficient MDS, providing mechanistic insights into how cooperative mutations drive stem cell expansion, inflammatory signaling, and myeloid skewing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026019911","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:11:15Z","timestamp":1790262675000},"page":"7690-7701","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["A CRISPR-based humanized model reveals a cooperative role of STAG2 loss in familial GATA2-deficient MDS progression"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3360-958X","authenticated-orcid":false,"given":"Grace","family":"Freed","sequence":"first","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Quijada-\u00c1lamo","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Lee","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"5Bioinformatics for Next Generation Sequencing, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2439-8733","authenticated-orcid":false,"given":"Ke","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3037-5519","authenticated-orcid":false,"given":"Nikita","family":"Poddar","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"5Bioinformatics for Next Generation Sequencing, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1386-7565","authenticated-orcid":false,"given":"Subrina","family":"Autar","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1510-1045","authenticated-orcid":false,"given":"Saul","family":"Carcamo","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"5Bioinformatics for Next Generation Sequencing, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8648-8739","authenticated-orcid":false,"given":"Persephone","family":"Fiore","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma K.","family":"Kim","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5372-3873","authenticated-orcid":false,"given":"Isabella G.","family":"Martinez","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3273-540X","authenticated-orcid":false,"given":"Mimi","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9590-400X","authenticated-orcid":false,"given":"Shayan","family":"Saniei","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2165-1386","authenticated-orcid":false,"given":"Clifford","family":"Chao","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4792-5356","authenticated-orcid":false,"given":"Levan","family":"Mekerishvili","sequence":"additional","affiliation":[{"name":"6Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY"},{"name":"7Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY"},{"name":"8Physiology, Biophysics and Systems Biology Graduate Program, Weill Cornell Medicine, New York, NY"},{"name":"9New York Genome Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5526-9077","authenticated-orcid":false,"given":"Zayna","family":"Diaz","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9785-7929","authenticated-orcid":false,"given":"Sai","family":"Ma","sequence":"additional","affiliation":[{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"10Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"11Institute of Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"12Skin Biology and Diseases Resource-Based Center, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7943-1636","authenticated-orcid":false,"given":"Dan","family":"Hasson","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"5Bioinformatics for Next Generation Sequencing, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvin","family":"Wagenblast","sequence":"additional","affiliation":[{"name":"1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"4Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"13Division of Pediatric Hematology-Oncology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY"},{"name":"14Mindich Child Health & Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2026111311223243300_bib1","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ajh.26984","article-title":"Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Garcia-Manero","year":"2023","journal-title":"Am J Hematol"},{"issue":"6","key":"2026111311223243300_bib2","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.3390\/ijms24065734","article-title":"The genetic landscape of myelodysplastic neoplasm progression to acute myeloid leukemia","volume":"24","author":"B\u0103nescu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2026111311223243300_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/j.seminhematol.2024.09.005","article-title":"Inflammation in myelodysplastic syndrome pathogenesis","volume":"61","author":"Rodriguez-Sevilla","year":"2024","journal-title":"Semin Hematol"},{"issue":"11","key":"2026111311223243300_bib4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"10","key":"2026111311223243300_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"issue":"4","key":"2026111311223243300_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjh.18330","article-title":"GATA2 deficiency and MDS\/AML: experimental strategies for disease modelling and future therapeutic prospects","volume":"199","author":"Kotmayer","year":"2022","journal-title":"Br J Haematol"},{"issue":"10","key":"2026111311223243300_bib7","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1182\/blood.V89.10.3636","article-title":"Transcription factor GATA-2 is required for proliferation\/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation","volume":"89","author":"Tsai","year":"1997","journal-title":"Blood"},{"issue":"13","key":"2026111311223243300_bib8","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood.2022017764","article-title":"The spectrum of GATA2 deficiency syndrome","volume":"141","author":"Calvo","year":"2023","journal-title":"Blood"},{"issue":"12","key":"2026111311223243300_bib9","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/s41375-025-02771-8","article-title":"CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness","volume":"39","author":"Romero-Moya","year":"2025","journal-title":"Leukemia"},{"issue":"8","key":"2026111311223243300_bib10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","article-title":"Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients","volume":"103","author":"Donadieu","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"2026111311223243300_bib11","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.3324\/haematol.2015.127092","article-title":"GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies","volume":"100","author":"Wang","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"2026111311223243300_bib12","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3324\/haematol.2022.282250","article-title":"Somatic genetic alterations predict hematological progression in GATA2 deficiency","volume":"108","author":"Largeaud","year":"2023","journal-title":"Haematologica"},{"issue":"1","key":"2026111311223243300_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/10428194.2024.2400210","article-title":"Untangling the loops of STAG2 mutations in myelodysplastic syndrome","volume":"66","author":"Sudunagunta","year":"2025","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2026111311223243300_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1182\/bloodadvances.2021005065","article-title":"ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome","volume":"6","author":"West","year":"2022","journal-title":"Blood Adv"},{"issue":"5","key":"2026111311223243300_bib15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.stem.2019.08.003","article-title":"Cohesin members Stag1 and Stag2 display distinct roles in chromatin accessibility and topological control of HSC self-renewal and differentiation","volume":"25","author":"Viny","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2026111311223243300_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41467-019-12726-0","article-title":"Functional profiling of single CRISPR\/Cas9-edited human long-term hematopoietic stem cells","volume":"10","author":"Wagenblast","year":"2019","journal-title":"Nat Commun"},{"issue":"6551","key":"2026111311223243300_bib16","doi-asserted-by":"crossref","first-page":"eabf6202","DOI":"10.1126\/science.abf6202","article-title":"Mapping the cellular origin and early evolution of leukemia in Down syndrome","volume":"373","author":"Wagenblast","year":"2021","journal-title":"Science"},{"issue":"8014","key":"2026111311223243300_bib17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41586-024-07388-y","article-title":"Mapping genotypes to chromatin accessibility profiles in single cells","volume":"629","author":"Izzo","year":"2024","journal-title":"Nature"},{"issue":"4","key":"2026111311223243300_bib18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1158\/2643-3230.BCD-24-0342","article-title":"Single-cell transcriptional atlas of human hematopoiesis reveals genetic and hierarchy-based determinants of aberrant AML differentiation","volume":"6","author":"Zeng","year":"2025","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"2026111311223243300_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41587-020-0605-1","article-title":"Cell type prioritization in single-cell data","volume":"39","author":"Skinnider","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2026111311223243300_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-022-00369-9","article-title":"Dlk1 maintains adult mice long-term HSCs by activating Notch signaling to restrict mitochondrial metabolism","volume":"12","author":"Huang","year":"2023","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2026111311223243300_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13619-023-00163-w","article-title":"Long-term expansion of human hematopoietic stem cells","volume":"12","author":"Liang","year":"2023","journal-title":"Cell Regen"},{"issue":"22","key":"2026111311223243300_bib23","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.313104","article-title":"c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation","volume":"18","author":"Wilson","year":"2004","journal-title":"Genes Dev"},{"issue":"6","key":"2026111311223243300_bib19","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"Zeng","year":"2022","journal-title":"Nat Med"},{"issue":"6","key":"2026111311223243300_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.stem.2008.09.005","article-title":"Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity","volume":"3","author":"Laurenti","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"21","key":"2026111311223243300_bib24","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.3390\/cancers15215297","article-title":"PI3K\/Akt\/mTOR signaling pathway in blood malignancies-new therapeutic possibilities","volume":"15","author":"Wiese","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"2026111311223243300_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","article-title":"NicheNet: modeling intercellular communication by linking ligands to target genes","volume":"17","author":"Browaeys","year":"2020","journal-title":"Nat Methods"},{"issue":"8","key":"2026111311223243300_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.exphem.2011.05.005","article-title":"MHC class II upregulation and colocalization with Fas in experimental models of immune-mediated bone marrow failure","volume":"39","author":"Erie","year":"2011","journal-title":"Exp Hematol"},{"issue":"16","key":"2026111311223243300_bib27","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1182\/blood.2024026271","article-title":"CD99 promotes self-renewal in hematopoietic stem cells and leukemia stem cells by regulating protein synthesis","volume":"146","author":"Ji","year":"2025","journal-title":"Blood"},{"issue":"16 suppl","key":"2026111311223243300_bib28","doi-asserted-by":"crossref","first-page":"e19014","DOI":"10.1200\/JCO.2022.40.16_suppl.e19014","article-title":"Characteristics and prognosis of mutated STAG2 myeloid neoplasms [abstract]","volume":"40","author":"Katamesh","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026111311223243300_bib30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1349-7006.2006.00356.x","article-title":"Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts","volume":"98","author":"Masuda","year":"2007","journal-title":"Cancer Sci"},{"issue":"1","key":"2026111311223243300_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cellimm.2009.10.009","article-title":"Dendritic cell-derived TNF-alpha is responsible for development of IL-10-producing CD4+ T cells","volume":"261","author":"Hirata","year":"2010","journal-title":"Cell Immunol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/22\/7690\/2600598\/blooda_adv-2026-019911-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/22\/7690\/2600598\/blooda_adv-2026-019911-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:22:40Z","timestamp":1794586960000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/22\/7690\/571177\/A-CRISPR-based-humanized-model-reveals-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,24]]},"references-count":32,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026,11,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026019911","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,24]]},"published":{"date-parts":[[2026,11,24]]}}}